Pharmaceutical compound
7-(2-Aminopropyl)benzofuran (7-APB) is a monoamine releasing agent and designer drug of the benzofuran family, albeit with a potency an order of magnitude less than 6-APB.[1][2] It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA).[1][2] The drug was detected as a novel designer drug, in Europe, by 2013.[3]
See also
References
- ^ a b c Rickli A, Kopf S, Hoener MC, Liechti ME (July 2015). “Pharmacological profile of novel psychoactive benzofurans”. British Journal of Pharmacology. 172 (13): 3412–3425. doi:10.1111/bph.13128. PMC 4500375. PMID 25765500.
- ^ a b Simmler LD, Liechti ME (2018). “Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances”. Handbook of Experimental Pharmacology. Vol. 252. pp. 143–164. doi:10.1007/164_2018_113. ISBN 978-3-030-10560-0. PMID 29633178.
- ^ Stanczuk A, Morris N, Gardner EA, Kavanagh P (April 2013). “Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in internet purchased products”. Drug Testing and Analysis. 5 (4): 270–276. doi:10.1002/dta.1451. PMID 23349125.
External links
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||